SEC Form 4 · accession 0001832579-26-000007
MARAVAI LIFESCIENCES HOLDINGS, INC. · MRVI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt Oreshack
Officer — General Counsel
Period of report
Jun 9, 2026
Accepted (ET)
Jun 10, 2026 · 5:06 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001823239
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 9, 2026 | S | 25,000 | $5.06 | D | 360,767 | D | |
| Class A Common StockF1 | Jun 10, 2026 | S | 25,000 | $5.10 | D | 335,767 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.